Anti-GCN2 antibody [EPR5970(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(2 Reviews)
|
(18 Publications)
Rabbit Recombinant Monoclonal GCN2 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 18 publications.
View Alternative Names
GCN2, KIAA1338, EIF2AK4, eIF-2-alpha kinase GCN2, Eukaryotic translation initiation factor 2-alpha kinase 4, GCN2-like protein
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Immunocytochemistry/ Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma cell line) cells labeling GCN2 with ab134053 at 1/250 dilution (4.0μg/ml). The cells were co-stained with ab195889, an Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 (2.5 μg/ml). Cells were fixed with 100% methanol. ab150077, a Goat anti-rabbit IgG(Alexa Fluor® 488) secondary antibody was used at 1/1000 dilution. DAPI was used as the nuclear counter stain.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carconoma tissue sections labeling GCN2 with purified ab134053 at 1/100 dilution (10 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, PH9. ab97051, a Goat Anti-Rabbit IgG H&L (HRP) secondary antibody was used at 1/500 dilution. Tissue was counterstained with hematoxylin. PBS instead of the primary antibody was used as the negative control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma cell line) cells labeling GCN2 with purified ab134053 at 1/100 dilution (10 ug/ml). Cells were fixed with 4% paraformaldehyde. A Goat anti-rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Rabbit monoclonal IgG (Black) was used as the isotypre control. Cells without incubation with the primary antibody and secondary antibody (Blue) is the unlabeled control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Immunofluorescence staining of MCF-7 cells with purified ab134053 at a working dilution of 1/500, counter-stained with DAPI. The secondary antibody was an Alexa Fluor® 488 conjugated goat anti-rabbit (ab150077), used at a dilution of 1/1000. The cells were fixed in 100% methanol. The negative control is shown in bottom right hand panel - for the negative control, PBS was used instead of the primary antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labelling GCN2 with unpurified ab134053 at 1/100 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Overlay histogram showing HeLa cells stained with unpurified ab134053 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab134053, 1/10000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- WB
Lab
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Lanes 1- 2 : Merged signal (red and green). Green - ab134053 observed at 187 kDa. Red - Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) observed at 50 kDa.
ab134053 was shown to react with GCN2 in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab267246 (knockout cell lysate ab256902) was used. Wild-type HEK-293T and EIF2AK4 knockout HEK-293T cell lysates were subjected to SDS-PAGE. ab134053 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
EIF2AK4 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human EIF2AK4 (GCN2) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-eif2ak4-gcn2-knockout-hek-293t-cell-line-ab267246'>ab267246</a>)
Predicted band size: 187 kDa
Observed band size: 187 kDa
false
- WB
Lab
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
ab134053 is more sensitive than ab302609 in WB testing.
Lanes 1 - 2:
Western blot - Anti-GCN2 antibody [EPR25345-125] (<a href='/en-us/products/primary-antibodies/gcn2-antibody-epr25345-125-ab302609'>ab302609</a>) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053) at 1/1000 dilution
Lanes 1 and 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lanes 2 and 4:
293T (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 187 kDa
false
Exposure time: 60s
- WB
Lab
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Lanes 1- 2 : Merged signal (red and green). Green - ab134053 observed at 187 kDa. Red - Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) observed at 50 kDa.
ab134053 was shown to react with GCN2 in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab267247 (knockout cell lysate ab256903) was used. Wild-type HEK-293T and EIF2AK4 knockout HEK-293T cell lysates were subjected to SDS-PAGE. ab134053 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
EIF2AK4 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human EIF2AK4 (GCN2) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-eif2ak4-gcn2-knockout-hek-293t-cell-line-ab267247'>ab267247</a>)
Predicted band size: 112 kDa,13 kDa,187 kDa,55 kDa,69 kDa
Observed band size: 187 kDa
false
- WB
Lab
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : GCN2 knockout HAP1 cell lysate (20 μg)
Lane 3 : MOLT4 cell lysate (20 μg)
Lane 4 : A549 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab134053 observed at 171 kDa. Red - loading control, ab18058, observed at 124 kDa.
Unpurified ab134053 was shown to recognize GCN2 when GCN2 knockout samples were used, along with additional cross-reactive bands. Wild-type and GCN2 knockout samples were subjected to SDS-PAGE. ab134053 and ab18058 (loading control to Vinculin) were diluted at 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053)
Predicted band size: 187 kDa,55 kDa
false
- WB
Unknown
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
All lanes:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
MOLT4 cell lysate at 10 µg
Lane 4:
A549 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 187 kDa
false
- WB
Lab
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Blocking and diluting buffer : 5% NFDM /TBST.
All lanes:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053) at 1/50000 dilution
All lanes:
MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 187 kDa
Observed band size: 187 kDa
false
- WB
Lab
Western blot - Anti-GCN2 antibody [EPR5970(2)] (AB134053)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GCN2 antibody [EPR5970(2)] (ab134053) at 1/10000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 15 µg
Lane 2:
HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 187 kDa
Observed band size: 187 kDa
false
Related conjugates and formulations (9)
-
Anti-GCN2 antibody [EPR5970(2)] - BSA and Azide free
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-GCN2 antibody [EPR5970(2)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-GCN2 antibody [EPR5970(2)]
-
660 APC
APC Anti-GCN2 antibody [EPR5970(2)]
-
578 PE
PE Anti-GCN2 antibody [EPR5970(2)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-GCN2 antibody [EPR5970(2)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-GCN2 antibody [EPR5970(2)]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-GCN2 antibody [EPR5970(2)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-GCN2 antibody [EPR5970(2)]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Bone research 13:47 PubMed40229258
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:50 PubMed39747098
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 9: PubMed39316438
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 25:4488-4514 PubMed39261742
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2401748 PubMed38994891
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e14799 PubMed37025861
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reports 17:2674-2689 PubMed36400028
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 8:eabo1304 PubMed36306353
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 34:1151-1167.e7 PubMed35839757
2022
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 23:e53373 PubMed34994492
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com